Ranbaxy Laboratories is a top pharmaceutical company based in Haryana, India.The company was founded by Ranbir Singh and Gurbax Singh in 1937 as a distributor for a Japanese company Shionogi.

Ranbaxy is a research based international pharmaceutical company and is engaged in the discovery, development, manufacture and sale of pharmaceutical products worldwide.

Report:  Partnering Agreements with Ranbaxy 2005-2013

Ranbaxy Laboratories is a top pharmaceutical company based in Haryana, India.

The company was founded by Ranbir Singh and Gurbax Singh in 1937 as a distributor for a Japanese company Shionogi.

Ranbaxy is a research based international pharmaceutical company and is engaged in the discovery, development, manufacture and sale of pharmaceutical products worldwide.

Ranbaxy is a vertically integrated company that develops, manufactures and markets Generic, Branded Generic, Value-added and Over-the-Counter (OTC) products, Anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates.

The company offers a large portfolio of over 500 molecules that cover multiple dosage forms including tablets, capsules, injectables, inhalers, ointments, creams and liquids.

The pharmaceutical formulations manufactured by the company covers the following therapy areas:

• Anti-infectives,
•  Cardiovascular,
•  Pain management,
• Central Nervous System (CNS),
• Gastrointestinal,
• Respiratory,
• Dermatology,
•  Orthopaedics,
• Nutritionals and Urology.

Ranbaxy Laboratories has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Ranbaxy has a long history of partnering, building numerous collaborative partnerships

Ranbaxy Laboratories announced over 44 partnering / licensing deals since 2005, with over 25 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in cardiovascular, anti-infectives, followed by oncology, psychiatry, gastrointestinal and dermatology

Ranbaxy Laboratories has also announced 4 M&A deals since 2005, with the lead deals being the acquisition of a majority stake of Ranbaxy by Japanese pharma giant Daiichi Sankyo

Report:  Partnering Agreements with Ranbaxy 2005-2013

Examples of recent partnering and licensing deals announced by Ranbaxy can be viewed in Current Partnering's Partnering Agreements with Ranbaxy 2005-2013  partnering activity review article.

Examples of recent M&A deals announced by Ranbaxy can be viewed in Current Partnering's Partnering Agreements with Ranbaxy 2005-2013 M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Ranbaxy 2005-2013

Available reports from Current Partnering

Report:  Partnering Agreements with Ranbaxy 2005-2013

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Ranbaxy

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Ranbaxy company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk